Survival in breast cancer patients with bone metastases and skeletal-related events: A population-based cohort study in Denmark (1999-2007)

Breast Cancer Research and Treatment

Volumn 129, Issue 2, 2011, Pages 495-503

  Yong, Mellissa ^a   Jensen, Annette Østergaard ^b   Jacobsen, Jacob Bonde ^b   Nørgaard, Mette ^b   Fryzek, Jon P ^c   Sørensen, Henrik Toft ^b  

^a AMGEN INC   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Epidemiology and Computational Biology Exponent   (United States)

Author keywords

Bone metastases; Breast cancer; Epidemiology; Mortality risk; Skeletal related events

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE; PROGESTERONE RECEPTOR;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; BONE INJURY; BONE METASTASIS; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; DENMARK; FEMALE; FRAGILITY FRACTURE; HUMAN; HYPERCALCEMIA; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; ORTHOPEDIC SURGERY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SPINAL CORD COMPRESSION;

BONE NEOPLASMS; BREAST NEOPLASMS; DENMARK; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; HYPERCALCEMIA; KAPLAN-MEIER ESTIMATE; NEOPLASM STAGING; ORTHOPEDIC PROCEDURES; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SPINAL CORD COMPRESSION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052611748     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1475-5     Document Type: Article

References (26)

1. Sundhedsstyrelsen (2009) Nye tal fra Sundhedsstyrelsen. Årgang 13(3)
2. KK Søgaard DP Cronin-Fenton L Pedersen HT Sørensen TL Lash 2008 Survival in Danish patients with breast cancer and inflammatory bowel disease: a nationwide cohort study Inflamm Bowel Dis 14 4 519 525 18069672 10.1002/ibd.20341 (Pubitemid 351571832)
3. WJ Louwman AC Voogd JA van Dijck GA Nieuwenhuijzen J Ribot JF Pruijt, et al. 2008 On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands Cancer Causes Control 19 1 97 106 18038250 10.1007/s10552-007-9075- 8 1:STN:280:DC%2BD1c%2FjvFOlug%3D%3D
4. RE Coleman RD Rubens 1987 The clinical course of bone metastases from breast cancer Br J Cancer 55 1 61 66 3814476 10.1038/bjc.1987.13 1:STN:280:DyaL2s7ivVOmug%3D%3D (Pubitemid 17234155)
5. RE Coleman 1997 Skeletal complications of malignancy Cancer 80 8 Suppl 1588 1594 9362426 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID- CNCR9>3.0.CO;2-G 1:STN:280:DyaK1c%2Fis1Onuw%3D%3D (Pubitemid 27444031)
6. F Saad A Lipton R Cook YM Chen M Smith R Coleman 2007 Pathologic fractures correlate with reduced survival in patients with malignant bone disease Cancer 110 8 1860 1867 17763372 10.1002/cncr.22991 (Pubitemid 47557312)
7. L Frank 2000 Epidemiology. When an entire country is a cohort Science 287 5462 2398 2399 10766613 10.1126/science.287.5462.2398 1:CAS:528: DC%2BD3cXitlKgtbY%3D (Pubitemid 30185417)
8. TF Andersen M Madsen J Jørgensen L Mellemkjoer JH Olsen 1999 The Danish National Hospital Register. A valuable source of data for modern health sciences Dan Med Bull 46 3 263 268 10421985 1:STN:280:DyaK1MzltVyrtw%3D%3D (Pubitemid 29299976)
9. HH Storm EV Michelsen IH Clemmensen J Pihl 1997 The Danish Cancer Registry-history, content, quality and use Dan Med Bull 44 5 535 539 9408738 1:STN:280:DyaK1c%2FntlSgtA%3D%3D
10. R Erichsen TL Lash SJ Hamilton-Dutoit B Bjerregaard M Vyberg L Pedersen 2010 Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank Clin Epidemiol 2010 2 51 56
11. DP Cronin-Fenton M Nørgaard J Jacobsen JP Garne M Ewertz TL Lash, et al. 2007 Comorbidity and survival of Danish breast cancer patients from 1995 to 2005 Br J Cancer 96 9 1462 1468 17406360 1:STN:280:DC%2BD2s3mt1Ogtg%3D%3D (Pubitemid 46685783)
12. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 373 383 3558716 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D (Pubitemid 17055592)
13. RW Thomsen HH Hundborg HH Lervang SP Johnsen HT Sørensen HC Schønheyder 2004 Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study Diabetes Care 27 1 70 76 14693969 10.2337/diacare.27.1.70 (Pubitemid 38196712)
14. CB Pedersen H Gøtzsche JO Møller PB Mortensen 2006 The Danish Civil Registration System. A cohort of eight million persons Dan Med Bull 53 4 441 449 17150149 (Pubitemid 44816920)
15. EV McCloskey JF Guest JA Kanis 2001 The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma Drugs 61 9 1253 1274 11511021 10.2165/00003495-200161090-00003 1:CAS:528:DC%2BD3MXmsVOks7g%3D (Pubitemid 32744407)
16. F Saad C Olsson CC Schulman 2004 Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care Eur Urol 46 6 731 739 15548440 10.1016/j.eururo.2004.08.016 (Pubitemid 39488403)
17. H Fleisch 1998 Bisphosphonates: mechanisms of action Endocr Rev 19 1 80 100 9494781 10.1210/er.19.1.80 1:CAS:528:DyaK1cXhtlagtLw%3D (Pubitemid 29122075)
18. GN Hortobagyi RL Theriault L Porter D Blayney A Lipton C Sinoff, et al. 1996 Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group N Engl J Med 335 24 1785 1791 8965890 10.1056/NEJM199612123352401 1:CAS:528:DyaK2sXntlek (Pubitemid 26412396)
19. RL Theriault A Lipton GN Hortobagyi R Leff S Glück JF Stewart, et al. 1999 Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group J Clin Oncol 17 3 846 854 10071275 1:CAS:528:DyaK1MXhvFGguro%3D (Pubitemid 29109314)
20. TJ Powles AHG Paterson A Nevantaus S Legault M Pajunen VA Tidy, et al. 1998 Adjuvant clodronate reduces the incidence of bone metastases in patients with primary operable breast cancer Proc ASCO 17 468
21. M Gnant B Mlineritsch W Schippinger G Luschin-Ebengreuth S Pöstlberger C Menzel, et al. 2009 Endocrine therapy plus zoledronic acid in premenopausal breast cancer N Engl J Med 360 7 679 691 19213681 10.1056/NEJMoa0806285 1:CAS:528:DC%2BD1MXhvVyisbk%3D
22. R Coleman N Bundred R De Boer A Llombarto ID Campbell P Neven 2009 Impact of zoledronic acid in post-menopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST, ZO-FAST, and E-ZO-FAST Cancer Res 70 4082 10.1158/0008-5472.SABCS-09-4082
23. Aø Jensen M Nørgaard M Yong JP Fryzek HT Sørensen 2009 Validity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer patients in the Danish National Registry of Patients Clin Epidemiol 1 101 108 20865091
24. EP Steinberg J Whittle GF Anderson 1990 Impact of claims data research on clinical practice Int J Technol Assess Health Care 6 2 282 287 2394561 10.1017/S0266462300000805 1:STN:280:DyaK3czmvVeisw%3D%3D (Pubitemid 20347848)
25. CJ Newschaffer TL Bush LT Penberthy 1997 Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data J Clin Epidemiol 50 6 725 733 9250271 10.1016/S0895-4356(97)00050-4 1:STN:280:DyaK2szptlygtA%3D%3D (Pubitemid 27341823)
26. M Wilchesky RM Tamblyn A Huang 2004 Validation of diagnostic codes within medical services claims J Clin Epidemiol 57 2 131 141 15125622 10.1016/S0895-4356(03)00246-4 (Pubitemid 38668607)